SCHEMBL13428494

SCHEMBL13428494

CC(C)(C)OC(=O)NCCNc1ncc(CO)cc1Cl

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STK17B O94768 1/20 0.54
STK17A Q9UEE5 1/20 0.54
LATS1 O95835 1/20 0.43
ALDH1A1 P00352 3/20 0.42
BCHE P06276 1/20 0.41
BRD4 O60885 3/20 0.40
MALT1 Q9UDY8 1/20 0.40
TDP1 Q9NUW8 1/20 0.39
IDO1 P14902 2/20 0.39
POLB P06746 1/20 0.38
SUV39H2 Q9H5I1 1/20 0.38
MEN1 O00255 1/20 0.37
GAA P10253 1/20 0.37
KMT2A Q03164 1/20 0.37
MAPT P10636 2/20 0.37
TRPV1 Q8NER1 1/20 0.37
HSP90AA1 P07900 1/20 0.37
XBP1 P17861 1/20 0.37
HTT P42858 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6059152 0.84 STK17B (0.42) STK17BSTK17AALDH1A1TDP1POLB
SCHEMBL13428487 0.83 STK17B (0.54) STK17BSTK17ALATS1ALDH1A1BCHE
SCHEMBL3826302 0.83 STK17B (0.54) STK17BSTK17ALATS1ALDH1A1BCHE
SCHEMBL3233440 0.81 ALDH1A1 (0.47) ALDH1A1TDP1POLBMEN1GAA
SCHEMBL19416940 0.80 TRPV1 (0.60) STK17BSTK17ALATS1ALDH1A1BRD4
SCHEMBL3223809 0.80 ALDH1A1 (0.51) STK17BSTK17ALATS1ALDH1A1BCHE
SCHEMBL3223820 0.80 ALDH1A1 (0.51) STK17BSTK17ALATS1ALDH1A1BCHE
SCHEMBL3220751 0.80 STK17B (0.50) STK17BSTK17ALATS1ALDH1A1BRD4
SCHEMBL13428547 0.76 STK17B (0.47) STK17BSTK17ALATS1ALDH1A1BCHE
SCHEMBL16000816 0.76 TRPV1 (0.51) STK17BSTK17ALATS1ALDH1A1BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100069388-A1 N-HYDROXYACRYLAMIDE COMPOUNDS ASTELLAS PHARMA INC. (JP) 2010-03-18 US disclosed
US-20100069388-A1 N-HYDROXYACRYLAMIDE COMPOUNDS ASTELLAS PHARMA INC. (JP) 2010-03-18 US disclosed
CN-101583599-A N-hydroxyacrylamide compounds ASTELLAS PHARMA INC (JP) 2009-11-18 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069388-A1 N-HYDROXYACRYLAMIDE COMPOUNDS HDAC1, HDAC11, HDAC2 STK17B 2348/4885STK17A 1986/4885LATS1 3043/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.